With the June launch of the pilot AMC against pneumococcal disease, manufacturers are now registering to participate
Geneva, 23 September 2009 - The Serum Institute is one of the companies that has begun the registration process in order to participate. Several companies have inquired about the pilot.
Information about the number and names of manufacturers is confidential unless a firm requests its information to be made public.
For more information about the AMC registration process please contact: email@example.com